Smithsonian Magazine on MSN
The FDA approves the first-ever gene therapy for deafness, which aims to restore hearing in kids with a rare inherited condition
On April 23, the Food and Drug Administration approved the first-ever gene therapy for a rare, congenital form of deafness.
MedPage Today on MSN
FDA Panel Gives Thumbs Down to Novel Strategy for Switching Breast Cancer Therapy
Panelists conflicted about positive trial's ability to validate biomarker-guided switching ...
Biohacking, often described as the practice of optimising physical and mental performance to extend lifespan and improve ...
"These so-called conversion practices or therapies are not only harmful, they are a profound violation of human dignity and ...
T-cell therapy is one of oncology's most powerful ideas: Harvest a cancer patient's own immune cells, genetically engineer ...
The treatment, developed by Regeneron Pharmaceuticals, is for a very rare form of deafness. But it represents a medical ...
Regeneron hauled in $3.6 billion during the first quarter of 2026, as analysts homed in on a slight Eylea HD miss and key ...
Ray Therapeutics has received priority medicines (PRIME) designation from the European Medicines Agency (EMA) for its RTx-015 ...
If you're interested in red light therapy, choose a device that fits your specific needs. Many of them claim results, but are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results